Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer

por Liu, Yang, Wang, Chang-Lin, Pang, Zhong-Qi, Gao, Ke, Shen, Lin-Kun, Xu, Wan-Hai, Ren, Ming-Hua
Publicado 2023

Comprehensive analysis of PRPF19 immune infiltrates, DNA methylation, senescence-associated secretory phenotype and ceRNA network in bladder cancer

por Wang, YaXuan, Wang, Jinfeng, He, JiaXing, Ji, Bo, Pang, ZhongQi, Wang, JianShe, Liu, Yang, Ren, MingHua
Publicado 2023

Comprehensive analysis of integrin αvβ3/α6β1 in prognosis and immune escape of prostate cancer

por Liu, Yang, He, Jia-Xin, Ji, Bo, Wang, Jin-Feng, Zhang, Lu, Pang, Zhong-Qi, Wang, Jian-She, Ding, Bei-Chen, Ren, Ming-Hua
Publicado 2023